blue cross blue shield plans reverse course on glp-1 coverage Why we are changing of drugs for weight loss Obesity Meds Advance, Insurance Retreats:

Material has been edited for length and content.

Myth: Compounded medications are not allowed because they arent brand name. Fact: The IRS cares about whether a medication is legally prescribed to treat a disease

Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes

A follow-up study is being conducted to gauge side effects reported by those taking GLP-1s